As the years pass, our bodies take on many changes. Some we can control and others, like Osteoarthritis (OA), are a little more out of our hands – but that doesn’t mean you have to let it control you! In this article, we will explore the connection between aging and OA, what causes it, how to manage your symptoms effectively so that you can age gracefully with an active lifestyle. So if you’re ready to get proactive about your health as you age and learn how to best manage the effects of osteoarthritis in your life, then stay tuned for some exciting tips. [Read more…]
Dubai First to Launch Innovative Stem Cell Therapy for Joint Disease
UAE residents will no longer need to travel abroad to receive stem cell therapy for joint disease
Dubai, United Arab Emirates, November 21 2017 – Bioscience Clinic FZ LLC located in Dubai Healthcare City is pleased to launch to its latest innovative stem cells therapy for treatment of joint disease. Established since 2012, Bioscience Clinic is Dubai’s first and most advanced clinic to use stem cells taken from adipose tissue in a variety of clinical applications. Its latest therapy was first introduced in Europe by Bioscience Institute, a Bioscience Clinic sister company. [Read more…]
Regeneus and AGC Asahi Glass Partner to Develop Progenza in Japan
Key Points
- Regeneus collaborates with AGC Asahi Glass (AGC), a world-leading manufacturer of glass, chemicals, high-tech materials and biopharmaceuticals, for exclusive manufacture of Progenza stem cell technology for Japanese market
- Regeneus to receive US$16.5m with $5.5m upfront and US$11m in specified milestone payments
- Regeneus and AGC establish 50/50 joint venture for exclusive clinical development and commercialisation of Progenza for osteoarthritis and all inflammatory conditions for Japanese market
- AGC to expand its leading biopharma manufacturing business into regenerative medicine products
Sydney, Australia – 29 December 2016 – Regeneus Ltd (ASX: RGS), a clinical-stage regenerative medicine company, today announced that it has entered into a strategic collaboration and licensing agreement with AGC Asahi Glass (AGC) (TYO:5201), a world-leading manufacturer of glass, chemicals, high-tech materials and biopharmaceuticals, for the manufacture, clinical development and commercialisation of Progenza, a patented off-the-shelf stem cell technology platform, for the Japanese market.